Ellie Yichen L.

Prime Discoveries develops rapid, novel diagnostics for emerging pathogen infections with a focus on cost effective, massively scalable and easily automatable assays. Prime leverages multiple patented advanced technologies in microbial diagnostics including RT-LAMP, Rapid PCR, and mNGS (Next generation sequencing) to enable samples to result in under 1 hour with minimal lab infrastructure and technical expertise. Prime’s products are best in class for Covid, Influenza, Sexually Transmitted Infections and new drug resistant microbes. All of Prime’s assays are locally developed in the United States and can serve millions of people. Founded in NYC in 2017, Prime’s scientists have extensive backgrounds in microbiology, computational biology, lab automation and AI from Genentech, Cooper Genomics, Recombine, Phosphorus, and NYU. Prime is advised by leading experts in the fields of genomics and public health including Dr. George Church and Esther Dyson. Prime is supported by academic institutions, venture capital firms and angel investors including New York University, Charles Zegar, BoxGroup, Akron Fusion Ventures, Beresford Ventures, Cannonball Capital, Liquid 2 Ventures, Francois Nader (Moderna, Acceleron, Shire), Unshackled Ventures, Doberman Forward, and others.

Prime Discoveries develops rapid, novel diagnostics for emerging pathogen infections with a focus on cost effective, massively scalable and easily automatable assays. Prime leverages multiple patented advanced technologies in microbial diagnostics including RT-LAMP, Rapid PCR, and mNGS (Next generation sequencing) to enable samples to result in under 1 hour with minimal lab infrastructure and technical expertise. Prime’s products are best in class for Covid, Influenza, Sexually Transmitted Infections and new drug resistant microbes. All of Prime’s assays are locally developed in the United States and can serve millions of people. Founded in NYC in 2017, Prime’s scientists have extensive backgrounds in microbiology, computational biology, lab automation and AI from Genentech, Cooper Genomics, Recombine, Phosphorus, and NYU. Prime is advised by leading experts in the fields of genomics and public health including Dr. George Church and Esther Dyson. Prime is supported by academic institutions, venture capital firms and angel investors including New York University, Charles Zegar, BoxGroup, Akron Fusion Ventures, Beresford Ventures, Cannonball Capital, Liquid 2 Ventures, Francois Nader (Moderna, Acceleron, Shire), Unshackled Ventures, Doberman Forward, and others.

Lair East Labs is a startup accelerator based in New York that empowers founders to expand internationally. At the heart of Lair East Labs lies the 4-month onsite accelerator. Each year 10 startups take on our program and receive investments of up to $150K. Our special 4-month program combines the best of two worlds - learn from alumni founders of top Silicon Valley-style accelerators and gain access to a mentor and investor network with extensive experience navigating the Asian markets. In the first five years of operation, our portfolio companies have raised $45 million of funding after completing the accelerator. At Lair East Labs, we help globally-minded founders scale their companies internationally. Leveraging acceleration, investment and an international community of like-minded people, we support founders in their quest to build successful and sustainable ventures that solve global problems. We are founders accelerating founders.